Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Steuber

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Leukemia Research|January 1, 1986
Effect of retinoic acid on myeloid antigen expression and clonal growth of leukemic cells from children with acute non lymphocytic leukemia--a Pediatric Oncology Group StudyH W Findley, C P Steuber, F B Ruymann, et al.
The Journal of Pediatrics|December 1, 1978
Sacrococcygeal chordoma in a neonate with multiple anomaliesW L Nix, C P Steuber, E P Hawkins, et al.
Medical and Pediatric Oncology|January 1, 1984
Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group studyE Hvizdala, D H Berry, T Chen, et al.
Leukemia|July 29, 2000
Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821M Chang, S C Raimondi, Y Ravindranath, et al.
Medical and Pediatric Oncology|January 1, 1993
Hodgkin's disease associated with central pontine myelinolysisM M Chintagumpala, D H Mahoney, K McClain, et al.
Cancer|January 15, 1985
Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded)M P Sullivan, J Boyett, J Pullen, et al.
Blood|August 15, 1993
Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group studyM J Borowitz, S P Hunger, A J Carroll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group studyY Ravindranath, C P Steuber, J Krischer, et al.
Investigational New Drugs|November 1, 1990
Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors. A Pediatric Oncology Group phase II studyR P Castleberry, A H Ragab, C P Steuber, et al.
Cancer Genetics and Cytogenetics|July 1, 1994
Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG) Study (8600/8493)M J Pettenati, N Rao, M Wofford, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Leukemia Research|January 1, 1986
Effect of retinoic acid on myeloid antigen expression and clonal growth of leukemic cells from children with acute non lymphocytic leukemia--a Pediatric Oncology Group StudyH W Findley, C P Steuber, F B Ruymann, et al.
The Journal of Pediatrics|December 1, 1978
Sacrococcygeal chordoma in a neonate with multiple anomaliesW L Nix, C P Steuber, E P Hawkins, et al.
Medical and Pediatric Oncology|January 1, 1984
Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group studyE Hvizdala, D H Berry, T Chen, et al.
Leukemia|July 29, 2000
Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821M Chang, S C Raimondi, Y Ravindranath, et al.
Medical and Pediatric Oncology|January 1, 1993
Hodgkin's disease associated with central pontine myelinolysisM M Chintagumpala, D H Mahoney, K McClain, et al.
Cancer|January 15, 1985
Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded)M P Sullivan, J Boyett, J Pullen, et al.
Blood|August 15, 1993
Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group studyM J Borowitz, S P Hunger, A J Carroll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group studyY Ravindranath, C P Steuber, J Krischer, et al.
Investigational New Drugs|November 1, 1990
Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors. A Pediatric Oncology Group phase II studyR P Castleberry, A H Ragab, C P Steuber, et al.
Cancer Genetics and Cytogenetics|July 1, 1994
Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG) Study (8600/8493)M J Pettenati, N Rao, M Wofford, et al.
Pageof 7